Viewing Study NCT04909450


Ignite Creation Date: 2025-12-24 @ 4:46 PM
Ignite Modification Date: 2025-12-28 @ 9:23 AM
Study NCT ID: NCT04909450
Status: COMPLETED
Last Update Posted: 2024-09-19
First Post: 2021-05-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Neurotrophic Keratitis Subjects
Sponsor: Claris Biotherapeutics, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module